Acute liver failure (ALF) is a rare, acute, potentially reversible condition resulting in severe
liver impairment and rapid clinical deterioration in patients without preexisting liver disease …

Primary biliary cholangitis (PBC) is a chronic immune-mediated liver disease with an
estimated global prevalence of 14.6 per 100,000 population (range from 1.91 to 40.2). 1, 2 …

Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease that is
characterized by the progressive destruction of small intrahepatic bile ducts resulting in …

Abstract Background and Aims While some articles describe outcome of pregnancy in
autoimmune hepatitis (AIH), there are less data evaluating influence of AIH control on …

自身免疫性肝炎(autoimmune hepatitis, AIH) 患者的临床特点包括血清氨基转移酶水平升高,
高免疫球蛋白G 血症, 血清自身抗体阳性, 肝组织学上存在中重度界面性肝炎等 …

Background & Aims Biochemical remission, important treatment goal in autoimmune
hepatitis (AIH), has been associated with better long-term survival. The aim of this study was …

Background No prognostic score is currently available for long‐term survival in autoimmune
hepatitis (AIH) patients. Objective The aim of this study was to develop and validate such a …

Acute presentation of autoimmune hepatitis (AIH) occurs in 22–43% of all AIH cases, and is
not a rare condition. Rather than constituting a single disease entity, it represents a clinical …

Abstract Introduction and Objectives Autoimmune liver diseases such as autoimmune
hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis are the primary …

Background and aim Acute severe autoimmune hepatitis (AS-AIH) is a rare cause of acute
liver failure (ALF), which is often neglected and delayed in treatment. The purpose of this …